Targeting RNA to treat neuromuscular disease.
The development of effective therapies for neuromuscular disorders such as Duchenne muscular dystrophy (DMD) is hampered by considerable challenges: skeletal muscle is the most abundant tissue in the body, and many neuromuscular disorders are multisystemic conditions. However, despite these barriers...
Main Authors: | Muntoni, F, Wood, M |
---|---|
格式: | Journal article |
語言: | English |
出版: |
2011
|
相似書籍
-
RNA-targeted splice-correction therapy for neuromuscular disease.
由: Wood, M, et al.
出版: (2010) -
Syncoilin upregulation in muscle of patients with neuromuscular disease.
由: Brown, S, et al.
出版: (2005) -
Splicing therapy for neuromuscular disease.
由: Douglas, A, et al.
出版: (2013) -
Syncoilin expression in neuromuscular disorders
由: Torelli, S, et al.
出版: (2001) -
Syncoilin expression in neuromuscular disorders.
由: Howman, E, et al.
出版: (2001)